The fact that in the GN-treated group, the GST levels were almost twofold higher than the controls, but SOD and GSPx were three times less, is another sign of GSH depletion, nephrotoxicity, and the activation of ferroptosis. The gene discussed is SOD1; the disease is ganglioneuroma.